EE200100320A - 6-asauratsiili derivaadid, nende valmistamismeetod ja kasutamine, kompositsioon ja selle valmistamismeetod, retseptori märgistamismeetod ja organi visualiseerimismeetod - Google Patents

6-asauratsiili derivaadid, nende valmistamismeetod ja kasutamine, kompositsioon ja selle valmistamismeetod, retseptori märgistamismeetod ja organi visualiseerimismeetod

Info

Publication number
EE200100320A
EE200100320A EEP200100320A EEP200100320A EE200100320A EE 200100320 A EE200100320 A EE 200100320A EE P200100320 A EEP200100320 A EE P200100320A EE P200100320 A EEP200100320 A EE P200100320A EE 200100320 A EE200100320 A EE 200100320A
Authority
EE
Estonia
Prior art keywords
preparation
composition
receptor labeling
azauracil derivatives
organ visualization
Prior art date
Application number
EEP200100320A
Other languages
English (en)
Estonian (et)
Inventor
Jean Edgard Freyne Eddy
Dirk Deroose Frederik
Fernand Armand Lacrampe Jean
Constant Johan Embrechts Werner
Michel Claude Fortin Jerome
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of EE200100320A publication Critical patent/EE200100320A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EEP200100320A 1998-12-18 1999-12-16 6-asauratsiili derivaadid, nende valmistamismeetod ja kasutamine, kompositsioon ja selle valmistamismeetod, retseptori märgistamismeetod ja organi visualiseerimismeetod EE200100320A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98204336 1998-12-18
PCT/EP1999/010169 WO2000037451A1 (en) 1998-12-18 1999-12-16 Il-5 inhibiting 6-azauracil derivatives

Publications (1)

Publication Number Publication Date
EE200100320A true EE200100320A (et) 2002-10-15

Family

ID=8234494

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100320A EE200100320A (et) 1998-12-18 1999-12-16 6-asauratsiili derivaadid, nende valmistamismeetod ja kasutamine, kompositsioon ja selle valmistamismeetod, retseptori märgistamismeetod ja organi visualiseerimismeetod

Country Status (35)

Country Link
US (1) US6803364B1 (pt)
EP (1) EP1140873B1 (pt)
JP (1) JP2002533331A (pt)
KR (1) KR100635721B1 (pt)
CN (1) CN100343239C (pt)
AR (1) AR021887A1 (pt)
AT (1) ATE365723T1 (pt)
AU (1) AU773780B2 (pt)
BG (1) BG105602A (pt)
BR (1) BR9916366A (pt)
CA (1) CA2354511A1 (pt)
CO (1) CO5150147A1 (pt)
CZ (1) CZ20012062A3 (pt)
DE (1) DE69936396T2 (pt)
DK (1) DK1140873T3 (pt)
EA (1) EA004806B1 (pt)
EE (1) EE200100320A (pt)
ES (1) ES2289835T3 (pt)
HK (1) HK1042491A1 (pt)
HR (1) HRP20010455A2 (pt)
HU (1) HUP0104641A3 (pt)
ID (1) ID28880A (pt)
IL (1) IL143766A (pt)
MY (1) MY125808A (pt)
NO (1) NO319814B1 (pt)
NZ (1) NZ512748A (pt)
PL (1) PL198205B1 (pt)
PT (1) PT1140873E (pt)
SA (1) SA00201030B1 (pt)
SK (1) SK8152001A3 (pt)
TR (1) TR200101729T2 (pt)
TW (1) TWI249530B (pt)
UA (1) UA73107C2 (pt)
WO (1) WO2000037451A1 (pt)
ZA (1) ZA200104942B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8466096B2 (en) * 2007-04-26 2013-06-18 Afton Chemical Corporation 1,3,2-dioxaphosphorinane, 2-sulfide derivatives for use as anti-wear additives in lubricant compositions
RU2523651C2 (ru) * 2012-05-22 2014-07-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Владивостокский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ВПО ВГМУ Минздравсоцразвития России) Способ дифференцированного контроля базисного противовоспалительного лечения бронхиальной астмы у детей и подростков
RU2506045C1 (ru) * 2012-09-05 2014-02-10 Федеральное государственное бюджетное учреждение "Дальневосточный научный центр физиологии и патологии дыхания" Сибирского отделения РАМН Способ прогнозирования достижения контроля бронхиальной астмы
CN119161311B (zh) * 2024-11-20 2025-02-11 北京纳百生物科技有限公司 一种地克珠利抗原及其合成方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2149645A1 (de) 1970-10-07 1972-09-14 Pfizer 2-Phenyl-as-triazin-3.5-(2H,4H)-dione und die Verwendung dieser Verbindungen zur Bekaempfung der Coccidiose
US3912723A (en) 1971-03-29 1975-10-14 Pfizer 2-Phenyl-as-triazine-3,5(2H,4H)diones
US3883528A (en) 1974-04-19 1975-05-13 Pfizer Preparation of 2(aryl)-as-triazine-3,5(2H,4H)-dione coccidiostats
CA1244024A (en) 1984-08-01 1988-11-01 Gustaaf M. Boeckx .alpha.- ARYL-4-(4,5-DIHYDRO-3,5-DIOXO-1,2,4-TRIAZIN- 2(3H)-YL)BENZENEACETONITRILES
US4631278A (en) 1984-08-01 1986-12-23 Janssen Pharmaceutica N.V. Anti-protozoal α-aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benzeneacetonitrile derivatives, pharmaceutical compositions, and method of use therefor
GB8602342D0 (en) 1986-01-30 1986-03-05 Janssen Pharmaceutica Nv 5 6-dihydro-2-(substituted phenyl)-1 2 4-triazine-3 5(2h 4h)-diones
CA1331757C (en) 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
EP0476439A1 (de) 1990-09-18 1992-03-25 Bayer Ag Substituierte 1,2,4-Triazindione, Verfahren zu ihrer Herstellung, Zwischenprodukte dafür und ihre Verwendung
DE4120138A1 (de) 1991-06-19 1992-12-24 Bayer Ag Substituierte hexahydro-1,2,4-triazindione, verfahren zu ihrer herstellung, zwischenprodukte dafuer und ihre verwendung
TW263495B (pt) 1992-12-23 1995-11-21 Celltech Ltd
GB9304920D0 (en) 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
TW403741B (en) 1993-10-15 2000-09-01 Takeda Chemical Industries Ltd Triazine derivative, production and use thereof
TW332201B (en) 1995-04-06 1998-05-21 Janssen Pharmaceutica Nv 1,3-Dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatives
EP0737672B1 (en) 1995-04-14 2001-10-04 Takeda Schering-Plough Animal Health K.K. Method of producing triazine derivatives
US5985875A (en) * 1996-08-30 1999-11-16 Takeda Chemical Industries, Ltd. 1,2,4-triazine-3, 5-dione derivatives, their production and use thereof
IL133916A0 (en) * 1997-07-10 2001-04-30 Janssen Pharmaceutica Nv Il-5 inhibiting 6-azauracil derivatives
WO1999002504A1 (en) * 1997-07-10 1999-01-21 Janssen Pharmaceutica N.V. 6-azauracil derivatives as il-5 inhibitors

Also Published As

Publication number Publication date
BG105602A (en) 2002-01-31
NZ512748A (en) 2004-05-28
HRP20010455A2 (en) 2002-06-30
SK8152001A3 (en) 2002-04-04
CO5150147A1 (es) 2002-04-29
IL143766A (en) 2005-11-20
PL198205B1 (pl) 2008-06-30
ATE365723T1 (de) 2007-07-15
HUP0104641A3 (en) 2003-01-28
HK1042491A1 (zh) 2002-08-16
ES2289835T3 (es) 2008-02-01
JP2002533331A (ja) 2002-10-08
NO319814B1 (no) 2005-09-19
AU2100100A (en) 2000-07-12
TWI249530B (en) 2006-02-21
HUP0104641A2 (hu) 2002-04-29
US6803364B1 (en) 2004-10-12
EA004806B1 (ru) 2004-08-26
UA73107C2 (en) 2005-06-15
CN100343239C (zh) 2007-10-17
SA00201030B1 (ar) 2006-10-11
EA200100677A1 (ru) 2001-12-24
KR20010080617A (ko) 2001-08-22
NO20012987D0 (no) 2001-06-15
WO2000037451A1 (en) 2000-06-29
CN1330643A (zh) 2002-01-09
AU773780B2 (en) 2004-06-03
ID28880A (id) 2001-07-12
KR100635721B1 (ko) 2006-10-17
BR9916366A (pt) 2001-09-18
EP1140873A1 (en) 2001-10-10
PT1140873E (pt) 2007-10-10
DE69936396T2 (de) 2008-06-19
NO20012987L (no) 2001-08-17
AR021887A1 (es) 2002-08-07
ZA200104942B (en) 2002-06-18
CZ20012062A3 (cs) 2002-03-13
EP1140873B1 (en) 2007-06-27
DK1140873T3 (da) 2007-10-15
CA2354511A1 (en) 2000-06-29
IL143766A0 (en) 2002-04-21
MY125808A (en) 2006-08-30
DE69936396D1 (de) 2007-08-09
TR200101729T2 (tr) 2001-10-22

Similar Documents

Publication Publication Date Title
EE05214B1 (et) Polool-IFN- β konjugaat, selle valmistamismeetod ja farmatseutiline kompositsioon
EE200100033A (et) Enterokattega ravimkoostis ja selle valmistamise meetod
EE200000680A (et) Enterokattega ravimkoostis ja selle valmistamise meetod
EE200000596A (et) Tienüülasolüülalkoksüetaanamiinderivaadid, nende ja nende soolade valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja kasutamine ning vaheühend ja selle valmistamismeetod
EE200000016A (et) IL-5 inhibeerivad 6-asauratsiili derivaadid, nende valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja selle valmistamismeetod, retseptori markeerimismeetod ja organi visualiseerimismeetod
EE05086B1 (et) Primidiini derivaadid, nende valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja selle valmistamismeetod, kombinatsioon ning saadus
EE04499B1 (et) A1-adenosiiniretseptori agonistid, nende valmistamismeetod ja kasutamine
EE03263B1 (et) Erütromütsiini derivaadid, nende valmistamismeetod, farmatseutiline kompositsioon ja vaheühendid
EE200000613A (et) Kinoliini derivaadid, nende valmistamismeetodid ja farmatseutilised kompositsioonid
NO20012058L (no) 2-ureido-tiazolderivater, fremgangsmåte for deres fremstilling og anvendelse som antitumormidler
EE04489B1 (et) Atsüülpseudodipeptiidid, nende valmistamise meetod ja neid sisaldavad farmatseutilised kompositsioonid
EE9500064A (et) Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid
EE03338B1 (et) Tromboosivastane ravim, selle valmistamise protsess ja kasutamine
ATE202361T1 (de) N6-heterocyclisch-substituierte adenosin-derivate
FI903298A7 (fi) 2-(aminoaryyli)indolit ja -indoliinit, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä
BR9611675A (pt) Processo para preparação de uma composição de asfalto
EE9800265A (et) Erütromütsiini derivaadid, nende valmistamismeetod ja kasutamine ravimitena
EE200000767A (et) Asendatud triasolopüridasiini derivaat, selle valmistamismeetod ja kasutamine ning farmatseutiline kompositsioon
FI962969A7 (fi) Indolijohdannaisia 5-HT1:n agonisteina
EE03825B1 (et) 2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE04346B1 (et) Asoolid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
NO20006460D0 (no) 4, 5, 6 og 7-Indol og indolinderivater, deres fremstilling og anvendelse
EE9800200A (et) Bensoüülguanidiini derivaadid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
EE200300153A (et) Östrogeeni retseptori modulaatorid, farmatseutiline kompositsioon ja selle valmistamismeetod
NO995097L (no) Fremgangsmåte for fremstilling av en asfaltsammensetning